Status:

COMPLETED

Home Monitoring in Cardiac Resynchronisation Therapy

Lead Sponsor:

Biotronik SE & Co. KG

Conditions:

Heart Failure, Congestive

Eligibility:

All Genders

18+ years

Brief Summary

In spite of success in the management of heart failure, repetitive rehospitalisation and high mortality rate remain a serious problem. Recent studies, especially the COMPANION trial, have demonstrated...

Detailed Description

Clinical investigations identified potential predictors for mortality and rehospitalisation events in heart failure patients. A selection of these predictors primarily composes the "Heart Failure Moni...

Eligibility Criteria

Inclusion

  • Written patient informed consent
  • Indication for CRT (biventricular or bifocal)
  • Sufficient GSM-network coverage in the patient's area
  • Stable residence during follow-up (anticipated)
  • at least 1 documented hospitalisation due to heart failure within 12 months before enrolment

Exclusion

  • Permanent atrial fibrillation
  • Myocardial infarction or instable Angina Pectoris within the last 3 months
  • Planned cardiac interventions within the next 3 months (e.g. PTCA, CABG, HTX)
  • Acute myocarditis
  • Life expectancy under 6 months
  • Pregnant or breast-feeding woman
  • Participation in another clinical study

Key Trial Info

Start Date :

March 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

513 Patients enrolled

Trial Details

Trial ID

NCT00376116

Start Date

March 1 2005

End Date

November 1 2008

Last Update

November 17 2008

Active Locations (82)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 21 (82 locations)

1

LKH-Universitätsklinikum Graz

Graz, Austria, 8036

2

Medizinische Universität Wien

Vienna, Austria, 1080

3

Fakultni nemocnice u Svety Anny

Brno, Czechia, 65691

4

IKEM

Prague, Czechia, 14021